Analysis of molecular mechanism and development of preventive methods against the radiation-induced lung fibrosis
放射性肺纤维化的分子机制分析及预防方法开发
基本信息
- 批准号:20790922
- 负责人:
- 金额:$ 2.33万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Young Scientists (B)
- 财政年份:2008
- 资助国家:日本
- 起止时间:2008 至 2009
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Radiation-induced lung injury is one of the major dose-limiting factors of radiotherapy for thoracic malignancies such as lung and breast cancers. Radiation-induced lung fibrosis develops several months to years after radiation exposure at least in the irradiated field. Moreover, there are non-negligible critical risks of developing generalized lung fibrosis that is usually life-threatening. Although many studies have tried to analyze the mechanisms underlying the pathogenesis of radiation-induced lung fibrosis, the mechanisms still remain unclear. Hence, the prevention of radiation-induced lung fibrosis is difficult to realize in a clinical set- ting although extensive efforts have been undertaken in the exploration of this condition. The present study examined whether Ulinastatin reduced radiation-induced lung fibrosis in C57BL/6J mice, the standard mouse strain for studying the pathophysiology of radiation-induced fibrosis. In addition, the therapeutic potential of Ulinastatin was analyzed for prolongation of the lifespan of mice irradiated with a significant dose for inducing lung fibrosis. The present study clearly indicated that administration of Ulinastatin reduced radiation-induced lung fibrosis in mice, and timing and the injection timing of Ulinastatin for irradiation was important. It is noteworthy that the Ulinastatin administration period, which caused positive suppression of lung fibrosis, corresponded to the period of the increase in TGF-β level by irradiation, and especially before reaching the peak level of TGF-β. Therefore, it was suggested that the suppression of lung fibrosis might be due to the suppression of TGF-β by Ulinastatin.
辐射引起的肺损伤是胸腔恶性肿瘤的主要剂量限制因子,至少在辐射范围内辐射后几个月至数年。 - HE机制。辐射诱导的肺部的发病机理仍然不清楚肺纤维化。 Ulinastatin在C57BL/6J小鼠中辐射的辐射肺fiblis,用于研究辐射诱导的纤维化病理生理学的标准小鼠菌株。用明显的剂量诱导肺纤维化。在TGF-β水平上,尤其是在达到TGF-β的峰值之前,肺纤维的抑制可能是由于WY抑制TGF-β。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Protective Effect of Urinary Trypsin Inhibitor on the Development of Radiation-Induced Lung Fibrosis in Mice
- DOI:10.1269/jrr.09108
- 发表时间:2010-05-01
- 期刊:
- 影响因子:2
- 作者:Katoh, Hiroyuki;Ishikawa, Hitoshi;Nakano, Takashi
- 通讯作者:Nakano, Takashi
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATOH Hiroyuki其他文献
KATOH Hiroyuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATOH Hiroyuki', 18)}}的其他基金
The therapeutic potential of GLP-1 receptor antagonists for the treatment of spinal cord injury
GLP-1受体拮抗剂治疗脊髓损伤的潜力
- 批准号:
18K09084 - 财政年份:2018
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Attempt to Establish the Technology for Estimating Real Irradiated Dose of Particle Therapy in a Living Body
尝试建立估计活体内粒子治疗实际照射剂量的技术
- 批准号:
25670527 - 财政年份:2013
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The Assessment of Health Related Quality of Life for the Patients Treated with Radiotherapy
放疗患者健康相关生活质量评估
- 批准号:
23791396 - 财政年份:2011
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Construction of therapeutic gene library for pancreatic cancer and development of specific therapeutic vector
胰腺癌治疗基因库的构建及特异性治疗载体的开发
- 批准号:
14370345 - 财政年份:2002
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of tumor specific viralvector and application for gene therapy against human pancreatic cancer
肿瘤特异性病毒载体的研制及其在人胰腺癌基因治疗中的应用
- 批准号:
12470232 - 财政年份:2000
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Specific Gene Therapy for Pancreatic Cancer
胰腺癌特异性基因治疗
- 批准号:
10470236 - 财政年份:1998
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Tumor Specific Gene Therapy for Pancreatic Cancer
胰腺癌的肿瘤特异性基因治疗
- 批准号:
09557099 - 财政年份:1997
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
低剂量辐射通过CXCR4途径介导糖尿病大鼠内皮祖细胞的归巢机制
- 批准号:81300660
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
电离辐射诱发间充质干细胞基因组非稳定性的研究
- 批准号:31070759
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
常山酮增强肺癌放疗效果同时预防放射性肺损伤的分子机制研究
- 批准号:30970864
- 批准年份:2009
- 资助金额:29.0 万元
- 项目类别:面上项目
Wnt/β-catenin信号通路介导microRNAs调控食管癌干细胞放射敏感性研究
- 批准号:30972962
- 批准年份:2009
- 资助金额:28.0 万元
- 项目类别:面上项目
相似海外基金
Topological semiconductors resonate with an elusive form of radiation
拓扑半导体与难以捉摸的辐射形式产生共振
- 批准号:
DP240101062 - 财政年份:2024
- 资助金额:
$ 2.33万 - 项目类别:
Discovery Projects
放射線治療の物理技術的品質管理における安全評価システムの開発
放射治疗物理技术质量控制安全评价体系的开发
- 批准号:
24K15811 - 财政年份:2024
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Can megafauna shift the carbon and surface radiation budgets of the Arctic?
巨型动物群能否改变北极的碳和地表辐射预算?
- 批准号:
NE/W00089X/2 - 财政年份:2024
- 资助金额:
$ 2.33万 - 项目类别:
Research Grant
A Unified Understanding of the Earth's Radiation Environment
对地球辐射环境的统一认识
- 批准号:
NE/Z000157/1 - 财政年份:2024
- 资助金额:
$ 2.33万 - 项目类别:
Research Grant
CAREER: Hybridization and radiation: Integrating across phylogenomics, ancestral niche evolution, and pollination biology
职业:杂交和辐射:系统基因组学、祖先生态位进化和授粉生物学的整合
- 批准号:
2337784 - 财政年份:2024
- 资助金额:
$ 2.33万 - 项目类别:
Continuing Grant